Latest filing published 06 Apr 2022 for Chinook Therapeutics, INC..
Filing timeline
BuySaleInsider track record
Versant Venture Capital VII, L.P.: trading record in brief
All filings by Versant Venture Capital VII, L.P. on record concern Chinook Therapeutics, Inc. The record holds 11 filings, for trades running from 27 August 2021 to 4 April 2022.
On the market, this insider has only sold: 6 sales, €24.2M in total. So far in 2022, the count stands at no purchases and 3 sales.
The newest entry dates from 6 April 2022: a transaction, in Chinook Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Versant Venture Capital VII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,194 shares0Common StockSEC:0000899243-22-014108:1
- 14,194 shares0Common StockSEC:0000899243-22-014108:2
- 11,726 shares0Common StockSEC:0000899243-22-014108:3
- 11,726 shares0Common StockSEC:0000899243-22-014108:4
- 709,953 shares0Common StockSEC:0000899243-22-014108:0
- 308,000 shares@ US$16.000217.9% of flowCommon StockSEC:0000899243-22-000946:1
- 92,000 shares@ US$16.00025.4% of flowCommon StockSEC:0000899243-22-000946:2
- 600,000 shares@ US$16.000258.2% of flowCommon StockSEC:0000899243-22-000946:0
- 261,902 shares@ US$14.0016.8% of flowCommon StockSEC:0000899243-21-034627:1
- 78,098 shares@ US$14.005.0% of flowCommon StockSEC:0000899243-21-034627:2
- 510,000 shares@ US$14.0041.8% of flowCommon StockSEC:0000899243-21-034627:0
11 of 11 declarations
